Literature DB >> 18712842

Biologic diversity of polyomavirus BK genomic sequences: Implications for molecular diagnostic laboratories.

C Luo1, M Bueno, J Kant, P Randhawa.   

Abstract

Data on polyomavirus genomic diversity has greatly expanded in the past few years. The implications of viral DNA sequence variation on the performance of molecular diagnostic assays have not been systematically examined. 716 BK, 1626 JC, and 73 SV40 virus sequences available in GenBank were aligned using Clustal-X. Five different published BKV PCR assays currently in use at major medical centers were evaluated for primer and probe mismatches with available GenBank sequences. Coverage of naturally occurring BKV strains varied amongst different assay methods. Targeted viral sequences showed major mismatch with primer or probe sequence in up to 30.7% of known BKV strains. BKV subtypes IVa, IVb, and IVc were more prone to this problem, reflecting common use of Type I Dun sequence for assay design. Despite the known polymorphism of this gene, 484 VP-1 sequences with conserved areas potentially suitable for PCR assay design are available. Assay targets in the Large T-antigen and agnogene are less subject to genetic variation, but sequence information corresponding to the latter two genes is available only for 164 and 174 published strains, respectively. Cross reactivity of appropriately selected BKV primers with JCV and SV40 sequences available in current databases was not a significant problem.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18712842      PMCID: PMC2906129          DOI: 10.1002/jmv.21281

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  38 in total

1.  Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathy.

Authors:  H H Hirsch; M Mohaupt; T Klimkait
Journal:  J Infect Dis       Date:  2001-12-01       Impact factor: 5.226

2.  Large T antigen on the simian virus 40 origin of replication: a 3D snapshot prior to DNA replication.

Authors:  Maria G Gomez-Lorenzo; Mikel Valle; Joachim Frank; Claudia Gruss; Carlos Oscar S Sorzano; Xiaojiang S Chen; Luis Enrique Donate; Jose Maria Carazo
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

3.  The SV40 T antigen modulates CBP histone acetyltransferase activity.

Authors:  Ester Valls; Xavier de la Cruz; Marian A Martínez-Balbás
Journal:  Nucleic Acids Res       Date:  2003-06-15       Impact factor: 16.971

4.  DNA sequencing of viral capsid protein VP-1 region in patients with BK virus interstitial nephritis.

Authors:  Parmjeet S Randhawa; K Khaleel-Ur-Rehman; Patricia A Swalsky; Abhay Vats; Velma Scantlebury; Ron Shapiro; Sydney Finkelstein
Journal:  Transplantation       Date:  2002-04-15       Impact factor: 4.939

5.  Quantitation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipients.

Authors:  A P Limaye; K R Jerome; C S Kuhr; J Ferrenberg; M L Huang; C L Davis; L Corey; C L Marsh
Journal:  J Infect Dis       Date:  2001-04-23       Impact factor: 5.226

6.  Viral regulatory region sequence variations in kidney tissue obtained from patients with BK virus nephropathy.

Authors:  Parmjeet Randhawa; Debbie Zygmunt; Ron Shapiro; Abhay Vats; K Weck; P Swalsky; Sydney Finkelstein
Journal:  Kidney Int       Date:  2003-08       Impact factor: 10.612

7.  Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients.

Authors:  Parmjeet Randhawa; Andrew Ho; Ron Shapiro; Abhay Vats; P Swalsky; Sydney Finkelstein; John Uhrmacher; Karen Weck
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

8.  The cap region of topoisomerase I binds to sites near both ends of simian virus 40 T antigen.

Authors:  Rupa Roy; Pamela Trowbridge; Zheng Yang; James J Champoux; Daniel T Simmons
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

9.  Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine.

Authors:  Ruchuang Ding; Mara Medeiros; Darshana Dadhania; Thangamani Muthukumar; David Kracker; Jin M Kong; Susanna R Epstein; Vijay K Sharma; Surya V Seshan; Baogui Li; Manikkam Suthanthiran
Journal:  Transplantation       Date:  2002-10-15       Impact factor: 4.939

10.  Experimental optimization of probe length to increase the sequence specificity of high-density oligonucleotide microarrays.

Authors:  Shingo Suzuki; Naoaki Ono; Chikara Furusawa; Akiko Kashiwagi; Tetsuya Yomo
Journal:  BMC Genomics       Date:  2007-10-16       Impact factor: 3.969

View more
  6 in total

1.  VP-1 quasispecies in human infection with polyomavirus BK.

Authors:  Chunqing Luo; Hans H Hirsch; Jeffrey Kant; Parmjeet Randhawa
Journal:  J Med Virol       Date:  2011-11-03       Impact factor: 2.327

2.  Intravenous Immunoglobulin Administration Significantly Increases BKPyV Genotype-Specific Neutralizing Antibody Titers in Kidney Transplant Recipients.

Authors:  Aurélie Velay; Morgane Solis; Ilies Benotmane; Pierre Gantner; Eric Soulier; Bruno Moulin; Sophie Caillard; Samira Fafi-Kremer
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

3.  Neutralizing Antibody-Mediated Response and Risk of BK Virus-Associated Nephropathy.

Authors:  Morgane Solis; Aurélie Velay; Raphaël Porcher; Pilar Domingo-Calap; Eric Soulier; Mélanie Joly; Mariam Meddeb; Wallys Kack-Kack; Bruno Moulin; Siamak Bahram; Françoise Stoll-Keller; Heidi Barth; Sophie Caillard; Samira Fafi-Kremer
Journal:  J Am Soc Nephrol       Date:  2017-10-17       Impact factor: 10.121

4.  Commercially available immunoglobulins contain virus neutralizing antibodies against all major genotypes of polyomavirus BK.

Authors:  P Randhawa; D V Pastrana; G Zeng; Y Huang; R Shapiro; P Sood; C Puttarajappa; M Berger; S Hariharan; C B Buck
Journal:  Am J Transplant       Date:  2015-03-03       Impact factor: 8.086

5.  BK polyomavirus subtype III in a pediatric renal transplant patient with nephropathy.

Authors:  Beatrix Kapusinszky; Sharon F Chen; Malaya K Sahoo; Martina I Lefterova; Lynn Kjelson; Paul C Grimm; Neeraja Kambham; Waldo Concepcion; Benjamin A Pinsky
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

Review 6.  Agnoprotein of mammalian polyomaviruses.

Authors:  Nancy Gerits; Ugo Moens
Journal:  Virology       Date:  2012-06-21       Impact factor: 3.616

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.